"Occult Blood" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemical, spectroscopic, or microscopic detection of extremely small amounts of blood.
| Descriptor ID |
D009780
|
| MeSH Number(s) |
E01.370.225.925 E05.200.925
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Occult Blood".
Below are MeSH descriptors whose meaning is more specific than "Occult Blood".
This graph shows the total number of publications written about "Occult Blood" by people in this website by year, and whether "Occult Blood" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 2 | 0 | 2 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 2 | 3 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 2 | 2 |
| 2005 | 1 | 1 | 2 |
| 2006 | 1 | 4 | 5 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 2 | 0 | 2 |
| 2010 | 0 | 1 | 1 |
| 2013 | 2 | 2 | 4 |
| 2014 | 0 | 3 | 3 |
| 2015 | 1 | 1 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 4 | 4 |
| 2022 | 1 | 2 | 3 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Occult Blood" by people in Profiles.
-
Prevalence of Sessile Serrated Lesions in Individuals With Positive Fecal Immunochemical Test Undergoing Colonoscopy: Results From a Large Nationwide Veterans Affairs Database. Gastroenterology. 2024 06; 166(6):1170-1173.e2.
-
An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles. Gut. 2023 10; 72(10):1904-1918.
-
Route to diagnosis of colorectal cancer and association with survival within the context of a bowel screening programme. Public Health. 2022 Oct; 211:53-61.
-
The COMPASS study: A prospective, randomized, multi-center trial testing the impact of a clinic-based intervention informing patients of colorectal cancer screening options on screening completion. Contemp Clin Trials. 2022 08; 119:106852.
-
Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial. Lancet Gastroenterol Hepatol. 2022 06; 7(6):513-521.
-
Colonoscopy-Related Adverse Events in Patients With Abnormal Stool-Based Tests: A Systematic Review of Literature and Meta-analysis of Outcomes. Am J Gastroenterol. 2022 03 01; 117(3):381-393.
-
Combining the quantitative faecal immunochemical test and full blood count reliably rules out colorectal cancer in a symptomatic patient referral pathway. Int J Colorectal Dis. 2022 Feb; 37(2):457-466.
-
The role of faecal calprotectin in the identification of colorectal neoplasia in patients attending for screening colonoscopy. Colorectal Dis. 2022 02; 24(2):188-196.
-
Low Prevalence of Screen-Detected Colorectal Cancer in an Average-Risk Population: The New Normal. Clin Gastroenterol Hepatol. 2022 Nov; 20(11):2650-2652.e1.
-
Colorectal cancer screening in African Americans: are we following the guidelines? Cancer Causes Control. 2021 Sep; 32(9):943-951.